Additionally, the Rs-2018 regimen showed a trend towards improved survival in both EFS and OS compared with the Rs-99 regimen, particularly in the high-risk subgroup, although it did not reach statistical significance.
← all excerpts
Clinical Characteristics and Survival Outcomes in a Cohort of Pediatric Rhabdomyosarcoma Patients: The Impact of Risk-Adapted Therapy.
2
—
—
The sentences
Instead, a descriptive analysis of the data revealed distinct trends: DPE appeared to offer a favorable trend for tumor control in extremity tumors.